Recent Advances in the Treatment of Thyroid Pathologies with Selenium-Containing Compounds, Nanoparticles and Nanocomplexes Based on Selenium and Selenoproteins.

IF 4.3 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY
Biological Trace Element Research Pub Date : 2026-10-01 Epub Date: 2026-07-24 DOI:10.1007/s12011-026-05252-w
Elena G Varlamova
{"title":"Recent Advances in the Treatment of Thyroid Pathologies with Selenium-Containing Compounds, Nanoparticles and Nanocomplexes Based on Selenium and Selenoproteins.","authors":"Elena G Varlamova","doi":"10.1007/s12011-026-05252-w","DOIUrl":null,"url":null,"abstract":"<p><p>Thyroid diseases are a pressing issue in modern medicine, making it crucial to develop new pharmacological agents with effective therapeutic properties. This review analyzes the latest research on the role of various compounds of the essential trace element selenium in maintaining normal thyroid hormone function. In recent decades, numerous studies have been published demonstrating the diverse therapeutic properties of selenium compounds of various origins, demonstrating the effectiveness of this trace element in combating diseases of various etiologies. It is known that the thyroid gland, an important endocrine organ, regulates the hormonal balance of the key hormones thyroxine and triiodothyronine, and the enzymes that play a key role in this regulation are selenium-containing deiodinases. This review presents the latest data on this regulation, as well as the role of other selenoproteins in mitigating thyroid pathological processes. In addition, the latest developments in nanoselenium-based drugs are presented and the mechanisms for regulating various thyroid pathologies using selenium-containing nanoparticles and nanocomplexes are described. The role of organic and inorganic selenium-based drugs is also described. Thus, the information presented in this review allows us to understand the latest trends in the development of new selenium-based drugs for maintaining normal thyroid function.</p>","PeriodicalId":8917,"journal":{"name":"Biological Trace Element Research","volume":" ","pages":"8196-8213"},"PeriodicalIF":4.3000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological Trace Element Research","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1007/s12011-026-05252-w","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/7/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Thyroid diseases are a pressing issue in modern medicine, making it crucial to develop new pharmacological agents with effective therapeutic properties. This review analyzes the latest research on the role of various compounds of the essential trace element selenium in maintaining normal thyroid hormone function. In recent decades, numerous studies have been published demonstrating the diverse therapeutic properties of selenium compounds of various origins, demonstrating the effectiveness of this trace element in combating diseases of various etiologies. It is known that the thyroid gland, an important endocrine organ, regulates the hormonal balance of the key hormones thyroxine and triiodothyronine, and the enzymes that play a key role in this regulation are selenium-containing deiodinases. This review presents the latest data on this regulation, as well as the role of other selenoproteins in mitigating thyroid pathological processes. In addition, the latest developments in nanoselenium-based drugs are presented and the mechanisms for regulating various thyroid pathologies using selenium-containing nanoparticles and nanocomplexes are described. The role of organic and inorganic selenium-based drugs is also described. Thus, the information presented in this review allows us to understand the latest trends in the development of new selenium-based drugs for maintaining normal thyroid function.

含硒化合物、纳米粒子和基于硒和硒蛋白的纳米复合物治疗甲状腺疾病的最新进展。
甲状腺疾病是现代医学亟待解决的问题,开发具有有效治疗性能的新型药物至关重要。本文综述了人体必需微量元素硒的各种化合物在维持正常甲状腺激素功能中的作用的最新研究进展。近几十年来,发表的大量研究表明,不同来源的硒化合物具有不同的治疗特性,证明了这种微量元素在对抗各种病因疾病方面的有效性。众所周知,甲状腺作为一个重要的内分泌器官,调节着关键激素甲状腺素和三碘甲状腺原氨酸的激素平衡,而在这一调节中起关键作用的酶是含硒脱碘酶。本文综述了这一调控的最新数据,以及其他硒蛋白在缓解甲状腺病理过程中的作用。此外,还介绍了纳米硒基药物的最新进展,并介绍了含硒纳米颗粒和纳米复合物调节各种甲状腺疾病的机制。介绍了有机和无机硒基药物的作用。因此,本综述提供的信息使我们能够了解以硒为基础的维持正常甲状腺功能的新药物的最新发展趋势。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biological Trace Element Research
Biological Trace Element Research 生物-内分泌学与代谢
CiteScore
8.70
自引率
10.30%
发文量
459
审稿时长
2 months
期刊介绍: Biological Trace Element Research provides a much-needed central forum for the emergent, interdisciplinary field of research on the biological, environmental, and biomedical roles of trace elements. Rather than confine itself to biochemistry, the journal emphasizes the integrative aspects of trace metal research in all appropriate fields, publishing human and animal nutritional studies devoted to the fundamental chemistry and biochemistry at issue as well as to the elucidation of the relevant aspects of preventive medicine, epidemiology, clinical chemistry, agriculture, endocrinology, animal science, pharmacology, microbiology, toxicology, virology, marine biology, sensory physiology, developmental biology, and related fields.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书